" /> Rivoceranib - CISMeF





Preferred Label : Rivoceranib;

NCIt synonyms : -Pyridinecarboxamide, N-(4-(1-cyanocyclopentyl)phenyl)-2-((4-pyridinylmethyl)amino)-; Apatinib Free Base;

NCIt related terms : Apatinib;

NCIt definition : An orally bioavailable, small-molecule receptor tyrosine kinase inhibitor with potential antiangiogenic and antineoplastic activities. Upon administration, rivoceranib selectively binds to and inhibits vascular endothelial growth factor receptor 2, which may inhibit VEGF-stimulated endothelial cell migration and proliferation and decrease tumor microvessel density. In addition, this agent mildly inhibits c-Kit and c-SRC tyrosine kinases.;

UNII : 5S371K6132;

InChIKey : WPEWQEMJFLWMLV-UHFFFAOYSA-N;

CAS number : 811803-05-1; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 811803-05-1 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : YN968D1 Free Base;

NCI Metathesaurus CUI : CL553441;

Codes from synonyms : 40;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
14/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.